Skip to search.
 FTSE 100 Down 1.43%

Abbott Laboratories (ABT)

-NYSE
49.74 Up 0.33(0.67%) 21:02
|After Hours: : 49.84 Up 0.10 (0.20%) 22:06 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:49.41
Open:49.02
Bid:49.74 x 300
Ask:50.94 x 200
1y Target Est:51.41
Beta:1.3
Next Earnings Date:22-Jul-15ABT Earnings announcement
Day's Range:48.92 - 50.12
52wk Range:39.28 - 50.47
Volume:5,783,811
Avg Vol (3m):4,628,180
Market Cap:74.05b
P/E (ttm):18.00
EPS (ttm):2.76
Div & Yield:0.96 (1.90%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABTUp 0.67%74.05b
NSRGYDown 0.56%N/A
RHHBYDown 0.23%N/A
TEVAUp 0.16%52.29b

Key Statistics

Forward P/E (1 yr):20.64
P/S (ttm):3.61
Ex-Dividend Date:13-Jul-15

Analysts

Annual EPS Est (Dec-15) :2.16
Quarterly EPS Est (Jun-15) :0.50
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.36

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; int... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback